Cocoon Bioscience was founded in 2022 with the aim of addressing bottlenecks related to protein production challenges faced in the fields of life science, pharmaceuticals, and the food industry. Our foundation is built upon a technology platform that has been developed and refined over a span of two decades.
Algenex starts to work on a unique and novel platform for protein expression: CrisBio®
Successful PoC of the technology and the pilot scale facility is inaugurated in 2020 to rear 1 million insect pupae annually
Full patent protection obtained for CrisBio® and animal health vaccine is approved by the European Medicines Agency
In Q4, Cocoon is created as a spin-off from Algenex with the goal of expanding its solutions for the cultivated meat and life sciences sectors
Cocoon successfully raised €15 Mn Series A funding, opening an R&D lab in Madrid, and a pilot facility in Bilbao
Opening of our industrial facility in Bilbao with a capacity of up to 20 kgs annually
Graduate in Business Administration with specialization in Management and Business Administration from the Deusto Business School
Over 25 years of experience in financial management of business groups in different industries, possessing solid management knowledge, leadership skills, and a strong sense of responsibility
